Sapna Shah

This profile gathers the share dealings of Sapna Shah in BioPharma Credit PLC. We count 3 filings; the first trade dates from 27 March 2024 and the latest from 25 March 2026.

No open-market sale appears; the market trades are 3 purchases worth €3.5M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at 1 purchase and no sales.

Half of the purchases are above €17k and half below. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 25 March 2026 came the latest disclosure, an open-market purchase for €3.5M in BioPharma Credit PLC. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.